Puma Biotechnology Q3 2023 Adj EPS $0.17 Beats $0.08 Estimate, Sales $56.10M Miss $57.95M Estimate
Portfolio Pulse from saritha@benzinga.com
Puma Biotechnology reported Q3 2023 earnings of $0.17 per share, beating the analyst consensus estimate of $0.08 by 112.5%. However, the company's quarterly sales of $56.10 million missed the analyst consensus estimate of $57.95 million by 3.19%.
November 02, 2023 | 8:18 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Puma Biotechnology's Q3 2023 earnings beat estimates but sales missed expectations.
Puma Biotechnology's earnings beat could potentially boost investor confidence, but the sales miss might offset this positive sentiment. The net impact on the stock price is uncertain in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100